KWKaren Warman

Karen Warman

*This is an algorithmically generated author record based on publicly available information.

Karen Warman has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Peak Flow Feedback Intervention Improves Underperception of Airflow Limitation in Pediatric Asthma: A Randomized Clinical Trial

    by Jonathan M. Feldman, Deepa Rastogi, Karen Warman, Denise Serebrisky, Kimberly Arcoleo

    Rationale: Underperception of asthma symptoms is associated with poor asthma outcomes. Objectives: We assessed the effects of a behavioral intervention for improving perception of airflow limitation and asthma outcomes. Methods: A two-arm randomized controlled trial compared peak expiratory flow (PEF) feedback versus supportive counseling. Latino and Black adolescents with asthma ages 10–17 years old and caregivers were recruited from hospitals in the Bronx, New York. PEF feedback sessions reviewed accuracy of PEF guesses and medication adherence data and targeted behavior change using motivational interviewing and problem-solving skills training. The supportive counseling group received emotional support related to asthma. Both groups received three sessions across 6 weeks. All participants were blinded to PEF while guessing PEF before intervention and at 1, 6, and 12-month follow-up. Children in the PEF feedback group saw actual PEF after guesses were locked in during the 6-week intervention. Participants and assessors were blinded to group assignment. The primary outcome was underperception of airflow limitation (divergence between actual PEF and guesses) on home spirometers. Secondary outcomes included daily PEF and forced expiratory volume in 1 second (FEV1), inhaled corticosteroid adherence measured by electronic monitors, Asthma Control Test, and emergency health care use for asthma. Results: The sample comprised 354 children (mean = 13.2 ± 2.2 yr; 62% Latino, 38% Black) and caregivers. The PEF feedback group (N = 153 analyzed) demonstrated greater improvements at 1-month follow-up on underperception of airflow limitation (difference-in-differences, −12.64; 95% confidence interval [CI], −17.54 to −7.74), percent personal best PEF (9.89; 95% CI, 7.13 to 12.65), percent predicted FEV1 (4.93; 95% CI, 0.95 to 8.90), and inhaled corticosteroid adherence (16.02; 95% CI, 7.15 to 24.89) compared with the supportive counseling group (N = 152 analyzed). At 12-month follow-up, the PEF feedback group maintained improvements on underperception of airflow limitation (−13.87; 95% CI, −19.03 to −8.71), maintained higher percentage personal best PEF (14.23; 95% CI, 11.37 to 17.08) and percent predicted FEV1 (5.62; 95% CI, 1.56 to 9.67), and had smaller declines in inhaled corticosteroid adherence (17.51; 95% CI, 7.12 to 27.89) versus before intervention than the supportive counseling group. No between-group differences existed for asthma control or health care use. Conclusions: The efficacy and sustainability of PEF feedback was established in improving children’s perception of airflow limitation, pulmonary function, and medication adherence. Clinical trial registered with www.clinicaltrials.gov (NCT02702687).


  • Open Access

    Get SMART: Teaching Pediatric Residents the 2020 Focused Asthma Updates' Recommendations for Symptom-Based Medication Increases

    by Karen L. Warman, Ellen Johnson Silver

    The 2020 Focused Asthma Updates introduced a paradigm shift in the treatment of asthma that includes symptom-based adjustments to outpatient asthma treatment that vary by age and severity. The length and complexity of the updates have made them challenging to adopt. We implemented an educational session among pediatric residents to increase their familiarity with, comprehension of, and plans to adopt two evidence-based recommendations introduced in the 2020 Updates for symptom-based therapy. Facilitators led groups of four to six pediatric residents in cased-based discussions during a 30-minute, ambulatory care–based session. One week prior, participants and facilitators received synopses of the 2007 Guidelines for the Diagnosis and Management of Asthma and the 2020 Updates. Facilitators also received a guide and scripts explaining new concepts, providing supporting data, and highlighting learning objectives. Retrospective pre/post surveys assessed participants’ familiarity with, comprehension of, and planned adoption of recommendations for intermittent steroids and single maintenance and reliever therapy (SMART) before and after the conference. The surveys also assessed prior exposure to the 2020 Updates and reflections on the educational session. There were 26 participants. Ratings of familiarity, comprehension, and adoption plans regarding the recommendations significantly improved (ps < .001, Wilcoxon signed rank test). The case-based approach was well received, and the material was deemed relevant. This educational session significantly increased pediatric residents’ familiarity with, comprehension of, and plans to adopt two new evidence-based treatments. Dissemination of this educational session may improve outpatient asthma management.


  • Are inner-city children with asthma receiving specialty care as recommended in national asthma guidelines?

    by Karen L. Warman, Ellen J. Silver

    Objective: To examine whether children with asthma in an urban health care network are receiving asthma specialty care, and which factors, if any, are associated with the receipt of this care, including child's racial/ethnic group, age, socio-economic status (SES), insurance, and/or acute care utilization. Methods: This study is a retrospective cohort study of children aged 7–17 years who received primary care at an urban medical center in 2012 and had a primary or secondary ICD9 code for asthma. Data on asthma-related health care utilization from 1997 to 2012 were accessed using a software application linked to the electronic medical record. Analyses included descriptive statistics (means and percentages) as well as bivariate and multivariable logistic regressions. Results: The participants were 4959 children (59% Hispanic and 37% Black, Non-Hispanic) with a mean age = 11.1 years ± 3.05, with 56.8% males. Only 19% of the children had outpatient asthma specialist care: pulmonary (16%) and/or allergy (7%). Only 42% with an asthma-related hospitalization had an outpatient asthma specialist visit. The receipt of specialty care did not vary by race/ethnicity, SES or private vs. public insurance, but was more likely with hospitalization for asthma (OR 3.4) or ≥2 lifetime ED visits (OR 2.6) and less likely for those who were uninsured (OR 0.7). Conclusions: In contrast to guideline recommendations, few inner-city children with high asthma morbidity in this sample had seen asthma specialists. Efforts are needed to ensure that inner-city children with asthma are receiving guideline-recommended asthma specialty care.


  • Modifiable Risk Factors for Asthma Morbidity in Bronx Versus Other Inner-City Children

    by Karen Warman, Ellen Johnson Silver, Pam R. Wood

    Background: Bronx children have higher asthma prevalence and asthma morbidity than other US children. Objective: To compare risk factors for asthma morbidity present in Bronx children with those of children from other US inner-city areas. Methods: Cross-sectional, multi-state study of 1772 children ages 5–11 yrs. old with persistent asthma. Parental responses to the Child Asthma Risk Assessment Tool for 265 Bronx children are compared with those of 1507 children from 7 other sites (1 Northeast, 2 South, 2 Midwest, 2 West). Results: Bronx children were significantly more likely to be sensitized to reported aeroallergens in their homes than were children from the other sites (86% vs. 58%; p <.001). More Bronx parents reported household cockroaches (65% v 20%; p <.001), mice (42% v 11%; p <.001), and rats (7% v 3%; p <.001); using a gas stove to heat the home (20% v 9%; p <.001); and visible mold (48% v 25%; p <.001). Bronx parents were more likely to report pessimistic beliefs about controlling asthma (63% v 26%; p <.001) and high parental stress (48% v 37%; p <.01). Conclusions: Compared with other inner-city children with asthma, Bronx children are more likely to be exposed to household aeroallergens to which they are sensitized and have poor housing conditions. Their parents are more likely to report low expectations for asthma control and high levels of psychological stress. Interventions that address these identified needs may help to reduce the disproportionate burden of asthma morbidity experienced by Bronx children.


  • The Relationship of Caretaker Anxiety to Children's Asthma Morbidity and Acute Care Utilization

    by Ellen Johnson Silver, Karen Warman, Ruth Stein

    This study examined self-reported psychological distress in caretakers of inner-city children with asthma and examined its association to disease severity, as measured by day and night symptoms, and to acute care utilization for asthma. We enrolled 193 English and Spanish-speaking caretakers (86% were mothers) of 2- to 12-year-olds who had at least one asthma hospitalization at a large urban medical center. They completed an interview asking about children's asthma symptoms and acute care utilization (provider visits, emergency department visits, hospitalizations for asthma) and a 29-item psychiatric symptom inventory. National guidelines criteria were used to classify asthma severity into three categories based on caretaker report of day and night symptoms in the past 4 weeks. These were: moderate-severe persistent (37%), mild persistent (27%), and mild intermittent (35%) asthma. Caretakers of children who were reported as having moderate-severe persistent asthma symptoms exhibited higher anxiety than caretakers reporting milder symptoms in their children, but symptom severity was unrelated to depression, anger, cognitive disturbance, or overall distress in caretakers. Three measures of acute care utilization in the last 6 months increased with reported symptom severity, but they were not associated with caretaker distress. Providers treating children with asthma should consider the potential importance of caretaker reports of daily symptoms both for the child's physical functioning and for parental anxiety.


  • Open Access

    If We Prescribe It, Will It Come?

    by Karen L. Warman, Amanda M. Jacobs, Ellen J. Silver

    Context Asthma is a major cause of morbidity in the United States. Self-management of asthma requires access to appropriate equipment. Clinical experience in an inner-city practice suggests that families encounter difficulties in filling prescriptions for spacers/holding chambers, peak flow (PF) meters, and nebulizer machines. Objectives To determine whether Bronx, NY, pharmacies (1) carry spacers/holding chambers, PF meters, and nebulizer machines; (2) accept Medicaid insurance for them; and (3) perceive barriers to reimbursement by Medicaid for this equipment. Design and Setting Structured telephone survey of 100 Bronx pharmacies randomly selected from the1999 telephone directory. Participants Ninety-eight pharmacists and 2 pharmacy technicians in 100 different pharmacies. Main Outcome Measures Pharmacists' reports of equipment availability, Medicaid acceptance, and reasons for not carrying equipment or accepting Medicaid. Results Overall equipment availability was as follows: spacers (68%), spacers with masks (57%), adult PF meters (40%), child-range PF meters (24%), and nebulizer machines (56%). For Medicaid recipients, equipment was less available: spacers (45%), spacers with masks (35%), adult PF meters (27%), child-range PF meters (17%), and nebulizer machines (33%). Surveyed pharmacists reported misconceptions about requirements for Medicaid reimbursement, which included the following: that Durable Medical Equipment permits are required (64% spacers and 33% PF meters), that special forms are needed (17% PF meters), or that this equipment is not covered by Medicaid (14% spacers and 8% PF meters). Of the 100 surveyed pharmacists, 32 reported difficulties with Medicaid reimbursement and 41 had never tried to receive reimbursement. Conclusions These results suggest that (1) access to spacers/holding chambers, PF meters, and nebulizers for Medicaid-insured families is severely limited in Bronx pharmacies; (2) misunderstandings regarding Medicaid reimbursement policies are common; and (3) interventions to increase the proportion of pharmacies that dispense equipment are needed.